BSE
MARKET ANALYSIS NEWS CORPORATE INFORMATION CORPORATE ACTIONS OTHER MARKETS
Your Result on : Company News
Natco Pharma Ltd Industry :  Pharmaceuticals - Indian - Bulk Drugs & Formln
BSE Code
524816
ISIN Demat
INE987B01026
Book Value (Rs)
461.79599
NSE Symbol
NATCOPHARM
Divident Yield %
0.73
Market Cap
(Rs In Cr.)
14,725
P/E (TTM)
9.7
EPS (TTM)
84.75
Face Value
(Rs)
2
Date Heading
16-Feb-26 Easy Trip Planners Ltd leads gainers in 'A' group
16-Feb-26 Volumes spurt at C.E. Info Systems Ltd counter
16-Feb-26 Volumes jump at Natco Pharma Ltd counter
14-Feb-26 Natco Pharma receives CDSCO approval for launch of Semaglutide in India
13-Feb-26 Natco Pharma receives USFDA EIR report for API unit in Chennai
12-Feb-26 Natco Pharma consolidated net profit rises 13.91% in the December 2025
12-Feb-26 Board of Natco Pharma recommends interim dividend
03-Feb-26 NATCO Pharma receives USFDA tentative approval for Erdafitinib tablets
30-Jan-26 NATCO Pharma Asia acquires 49% stake in PT NATCO Lotus Farma
28-Jan-26 Natco Pharma to hold board meeting
02-Dec-25 Natco Pharma announces change in senior management
29-Nov-25 Natco Pharma receives affirmation in credit ratings from ICRA
27-Nov-25 Whirlpool of India Ltd leads losers in 'A' group
26-Nov-25 Volumes soar at Carborundum Universal Ltd counter
26-Nov-25 Carborundum Universal Ltd leads gainers in 'A' group
Risk Factor   |   Terms & Conditions   |   Privacy Policy   |   Disclaimer   |  Sitemap 
Important Links:   SEBI   |   NSE   |   BSE   |   MCX   |   NCDEX   |   NSDL   |   CDSL  |   FMC
SMS FINANCIAL SERVICES P. LTD -NSE SEBI No. AP1413004363 | BSE SEBI No. AP01091801121968
Ganesh S Shanbhag – AMFI Registered Mutual Fund Distributor. Registration Number – ARN-0988 – Valid Till 01/JUL/ 2027, Date of initial registration: 02/DEC/2004
2017-18 © SMS Financial Services. All rights reserved. Designed, Developed and Maintained by CMOTS InfoTech (ISO 9001:2015 & ISO/IEC 27001:2022 Certified)